CAI · Healthcare · $8.7B
$29.07-5.09%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출이 1분기 2억1,600만 달러에서 2분기 2억6,370만 달러로 반등했고, 전년 동기 대비 증가율도 45%까지 커졌어요.”
In the company's words · 2026 2분기 earnings call